Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page

Q2-2020 Home Health & Hospice Update

Skip to the end of the Expertise Menu

Q2-2020 Home Health & Hospice Update

While the home health and hospice M&A landscape remains relatively strong, deal closings have undoubtedly slowed in the first half of 2020. Strategic acquirers have continued to be active but some private equity investors have delayed pursuing new home health platforms until there is further insight on the long-term impact of PDGM, which has been further clouded due to disruption from COVID-19.

Hospice, on the other hand, has seen little disruption and continues to see a high level of demand from both strategic and private equity investors. Evident by Amedisys’ acquisition of AseraCare Hospice, investors have and will continue to pay premium valuation multiples for hospice organizations.

To print and download the full Home Health & Hospice Update report, please click below…

[holo_button icon=”” link=”/wp-content/uploads/2020/07/Q2-2020-Home-Health-Hospice-Newsletter.pdf” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]


Sources: SEC Filings; Company Press Releases, and Reports; IBISWorld; Capital IQ; PHP Estimates and Research. This document has been compiled with publicly available information. Provident Healthcare Partners, LLC makes no guarantee of its accuracy or completeness. No data or statement should be construed to be a recommendation for the purchase, sale, or retention of any security.